Aariya Regulatory Launches eCTD Publishing Services

Press Release : June 01, 2020
Aariya Regulatory Launches eCTD Publishing Services

Aariya Regulatory, one of the most trusted names to offer specialized regulatory services for global generic and bio-pharma companies, today announced the launch of eCTD publishing services using licensed software to prepare, submit and maintain electronic dossiers for ANDA, IND, NDA, MAA and lifecycle submissions.

On this occasion, Sachin Verma, Founder and Director of Aariya Regulatory Services was quoted saying “If you decide to go eCTD but don’t want to commit to an in-house soft- and/or hardware solution yet, with eCTD Solutions we at Aariya can now offer a complete package of eCTD submission service at your disposal.” “We are confident that the tools included in the eCTD software package is going to significantly reduce our effort hours and will now help us offer an unmatched level of personalized service to our clients” added Pallab Roy, Co-founder and Chief Regulatory Consultant of Aariya.

Aariya can now assist their existing as well as future clients with all aspects of eCTD submissions for all major markets, including (but not limited to) the US (FDA), EU region, Switzerland (Swissmedic), Canada (Health Canada), Australia (TGA) / New Zealand (Medsafe), South Africa (MCC), GCC (SFDA), Jordan (JFDA) and Thailand (FDA).

About AARIYA Regulatory

Founded on the principle of clients being the real assets as well as the biggest advocates of a consulting service company, AARIYA Regulatory provides sustainable outsourcing of all regulatory affairs services across all major markets around the globe, which any generic pharmaceutical organization requires to sharpen their competitive edge in this era of cut-throat competition. Be it simple market intelligence, new submission guidance, life-cycle management, electronic publishing assistance or more complex expertise such as building the regulatory strategy, AARIYA continues to evolve its offerings and lead in the definition and execution of new business models for the generic pharmaceutical industry. For more information, visit www.aariya.net.

Contacts

Aariya Regulatory Contact:
+1-609-945-3618
contact@aariya.net

Notes to editors

For more information please contact:
Pallab Roy Tel: +1-609-945-3618 email: contact@aariya.net Visit the newsroom of: sampr